[
    [
        {
            "time": "",
            "orginal_text": "新趋势？云南白药借力场外衍生品交易控制股份回购成本",
            "features": {
                "keywords": [
                    "云南白药",
                    "场外衍生品",
                    "股份回购"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "新趋势？云南白药借力场外衍生品交易控制股份回购成本",
            "scores": {
                "News_content": "新趋势？云南白药借力场外衍生品交易控制股份回购成本",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "股王涨276倍 医药生物行业的十倍牛股达39只",
            "features": {
                "keywords": [
                    "股王",
                    "医药生物",
                    "十倍牛股"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "股王涨276倍 医药生物行业的十倍牛股达39只",
            "scores": {
                "News_content": "股王涨276倍 医药生物行业的十倍牛股达39只",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "5·19行情21周年：股王涨276倍，十倍股165只！基金看好三大牛股“摇篮”",
            "features": {
                "keywords": [
                    "5·19行情",
                    "股王",
                    "十倍股",
                    "基金"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "5·19行情21周年：股王涨276倍，十倍股165只！基金看好三大牛股“摇篮”",
            "scores": {
                "News_content": "5·19行情21周年：股王涨276倍，十倍股165只！基金看好三大牛股“摇篮”",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "orginal_text": "福布斯最新上市公司2000强：CVS超辉瑞成新霸主！16家中国药企入围，翰森超越中生",
            "features": {
                "keywords": [
                    "福布斯",
                    "上市公司2000强",
                    "CVS",
                    "辉瑞",
                    "中国药企",
                    "翰森"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "福布斯最新上市公司2000强：CVS超辉瑞成新霸主！16家中国药企入围，翰森超越中生",
            "scores": {
                "News_content": "福布斯最新上市公司2000强：CVS超辉瑞成新霸主！16家中国药企入围，翰森超越中生",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "16家中国药企上榜2020年“全球上市公司2000强”",
            "features": {
                "keywords": [
                    "中国药企",
                    "全球上市公司2000强"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "16家中国药企上榜2020年“全球上市公司2000强”",
            "scores": {
                "News_content": "16家中国药企上榜2020年“全球上市公司2000强”",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "orginal_text": "芯片股大涨420亿中芯国际飙升8% 北上资金继续扫货25亿",
            "features": {
                "keywords": [
                    "芯片股",
                    "中芯国际",
                    "北上资金"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "半导体"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "芯片股大涨420亿中芯国际飙升8% 北上资金继续扫货25亿",
            "scores": {
                "News_content": "芯片股大涨420亿中芯国际飙升8% 北上资金继续扫货25亿",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "第一个重要的时间之窗来临",
            "features": {
                "keywords": [
                    "时间之窗"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "第一个重要的时间之窗来临",
            "scores": {
                "News_content": "第一个重要的时间之窗来临",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "重仓股上海家化月涨逾50% 裘国根迎来价值回归时刻",
            "features": {
                "keywords": [
                    "上海家化",
                    "裘国根",
                    "价值回归"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费品"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "重仓股上海家化月涨逾50% 裘国根迎来价值回归时刻",
            "scores": {
                "News_content": "重仓股上海家化月涨逾50% 裘国根迎来价值回归时刻",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "资金汇集白马股，A股千亿市值军团扩至近百家",
            "features": {
                "keywords": [
                    "白马股",
                    "A股",
                    "千亿市值"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "资金汇集白马股，A股千亿市值军团扩至近百家",
            "scores": {
                "News_content": "资金汇集白马股，A股千亿市值军团扩至近百家",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "【中信建投医药 | 行业周报】5月报前瞻正在逐步兑现，继续看好“疫情后修复”与“新基建”",
            "features": {
                "keywords": [
                    "中信建投",
                    "医药",
                    "疫情后修复",
                    "新基建"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "【中信建投医药 | 行业周报】5月报前瞻正在逐步兑现，继续看好“疫情后修复”与“新基建”",
            "scores": {
                "News_content": "【中信建投医药 | 行业周报】5月报前瞻正在逐步兑现，继续看好“疫情后修复”与“新基建”",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]